Altimmune (ALT) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.29% |
| Dec 31, 2025 | -29.71% |
| Sep 30, 2025 | -15.11% |
| Jun 30, 2025 | -22.21% |
| Mar 31, 2025 | -304.94% |
| Dec 31, 2024 | 73.45% |
| Sep 30, 2024 | 15.48% |
| Jun 30, 2024 | 9.40% |
| Mar 31, 2024 | -34.66% |
| Dec 31, 2023 | -55.51% |
| Sep 30, 2023 | 45.66% |
| Jun 30, 2023 | 3.48% |
| Mar 31, 2023 | -49.11% |
| Dec 31, 2022 | 12.83% |
| Sep 30, 2022 | 6.17% |
| Jun 30, 2022 | 24.49% |
| Mar 31, 2022 | 5.44% |
| Dec 31, 2021 | 4.78% |
| Sep 30, 2021 | 8.24% |
| Jun 30, 2021 | 3.83% |
| Mar 31, 2021 | -4.90% |
| Dec 31, 2020 | -50.43% |
| Sep 30, 2020 | -78.87% |
| Jun 30, 2020 | -143.56% |
| Mar 31, 2020 | 11.59% |
| Dec 31, 2019 | 4.99% |
| Sep 30, 2019 | 6.01% |
| Jun 30, 2019 | 8.40% |
| Mar 31, 2019 | -30.25% |
| Dec 31, 2018 | -335.58% |
| Sep 30, 2018 | -50.02% |
| Jun 30, 2018 | 53.96% |
| Mar 31, 2018 | 26.58% |
| Dec 31, 2017 | 7.84% |
| Sep 30, 2017 | -103.71% |
| Jun 30, 2017 | -208.15% |
| Mar 31, 2017 | 96.07% |
| Dec 31, 2016 | 48.74% |
| Sep 30, 2016 | -487.05% |
| Jun 30, 2016 | -62.68% |
| Mar 31, 2016 | -206.89% |
| Dec 31, 2015 | 73.32% |
| Sep 30, 2015 | 5.55% |
| Jun 30, 2015 | -17.09% |
| Mar 31, 2015 | 15.65% |
| Dec 31, 2014 | 4.98% |
| Sep 30, 2014 | -74.17% |
| Jun 30, 2014 | -18.15% |
| Mar 31, 2014 | 9.03% |
| Dec 31, 2013 | 34.26% |
| Sep 30, 2013 | -0.97% |
| Jun 30, 2013 | -22.66% |
| Mar 31, 2013 | -1.35% |
| Dec 31, 2012 | 13.75% |
| Sep 30, 2012 | -25.04% |
| Jun 30, 2012 | 23.05% |
| Mar 31, 2012 | -36.20% |
| Dec 31, 2011 | -7.98% |
| Sep 30, 2011 | 26.51% |
| Jun 30, 2011 | -45.86% |
| Mar 31, 2011 | 17.62% |
| Dec 31, 2010 | -333.64% |
| Sep 30, 2010 | -298.50% |